1. Home
  2. FGEN vs MNY Comparison

FGEN vs MNY Comparison

Compare FGEN & MNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FGEN
  • MNY
  • Stock Information
  • Founded
  • FGEN 1993
  • MNY 2014
  • Country
  • FGEN United States
  • MNY Singapore
  • Employees
  • FGEN N/A
  • MNY N/A
  • Industry
  • FGEN Biotechnology: Pharmaceutical Preparations
  • MNY
  • Sector
  • FGEN Health Care
  • MNY
  • Exchange
  • FGEN Nasdaq
  • MNY Nasdaq
  • Market Cap
  • FGEN 33.5M
  • MNY 31.9M
  • IPO Year
  • FGEN 2014
  • MNY N/A
  • Fundamental
  • Price
  • FGEN $5.85
  • MNY $1.08
  • Analyst Decision
  • FGEN Strong Buy
  • MNY Strong Buy
  • Analyst Count
  • FGEN 1
  • MNY 1
  • Target Price
  • FGEN $250.00
  • MNY $4.00
  • AVG Volume (30 Days)
  • FGEN 61.5K
  • MNY 187.9K
  • Earning Date
  • FGEN 08-05-2025
  • MNY 06-13-2025
  • Dividend Yield
  • FGEN N/A
  • MNY N/A
  • EPS Growth
  • FGEN N/A
  • MNY N/A
  • EPS
  • FGEN N/A
  • MNY N/A
  • Revenue
  • FGEN $6,996,000.00
  • MNY $71,649,746.00
  • Revenue This Year
  • FGEN N/A
  • MNY $31.98
  • Revenue Next Year
  • FGEN N/A
  • MNY $10.97
  • P/E Ratio
  • FGEN N/A
  • MNY N/A
  • Revenue Growth
  • FGEN N/A
  • MNY N/A
  • 52 Week Low
  • FGEN $4.50
  • MNY $0.55
  • 52 Week High
  • FGEN $38.25
  • MNY $1.86
  • Technical
  • Relative Strength Index (RSI)
  • FGEN 43.29
  • MNY 72.75
  • Support Level
  • FGEN $5.37
  • MNY $0.99
  • Resistance Level
  • FGEN $5.73
  • MNY $1.10
  • Average True Range (ATR)
  • FGEN 0.41
  • MNY 0.09
  • MACD
  • FGEN 0.07
  • MNY 0.04
  • Stochastic Oscillator
  • FGEN 77.78
  • MNY 95.45

About FGEN FibroGen Inc

FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.

About MNY MoneyHero Limited

MoneyHero Ltd is a personal finance aggregation and comparison company in Greater Southeast Asia. The firm is involved in the operation of online financial comparison platforms and related services for credit cards, personal loans, mortgages, insurance, and other financial products, connecting the providers of these products with well-matched and ready-to-transact consumers and generating revenue directly from these providers for placing their products on its platforms and providing insurance brokerage, marketing and events-related services. Geographically it operates in Singapore, Hong Kong, Taiwan, Malaysia and the Philippines.

Share on Social Networks: